September 11, 2026
TechCrunch is down to its last week for exhibit tables at Disrupt 2026, and the window to apply for an official Side Event closed last night at 11:59 p.m. PT. On the surface this is just conference logistics -- book your table, submit your event, move on. But the urgency itself is a signal worth reading. When a flagship tech conference is fielding enough demand to run 'final, final, final call' messaging, it tells you the market for in-person AI exposure hasn't cooled even as the headlines get noisier and more skeptical about AI valuations, safety, and hype fatigue. Founders and vendors are still willing to pay real money to stand in a room and be seen.
That matters for anyone evaluating AI tools right now, because conferences like Disrupt are where a lot of the year's loudest claims get made -- and where the gap between demo-stage polish and production-ready software is hardest to spot. Our advice hasn't changed: a booth pitch is not due diligence. If you're comparing AI-driven platforms after a conference floor, treat what you saw as a lead, not a decision, and go check how a tool actually performs against your existing stack before you sign anything.
The more interesting headline to us is that Mark Wahlberg is joining Bruce K. Lee on the Disrupt stage -- and, notably, TechCrunch says he wants to talk about attendees' work, not his own. That framing is a small but telling shift. Celebrity keynotes at tech events used to be about star power and ticket sales. Positioning Wahlberg as someone probing founders about investing, entrepreneurship, healthcare, and wellness suggests organizers think the audience wants operator insight more than a photo op. It's a bet that credibility now sells better than celebrity, even when the celebrity is the draw.
We'd take that as a good sign for the industry's maturity, with one caveat: wellness and healthcare are exactly the sectors where AI hype has outrun substance the most this year, from diagnostic claims to consumer wellness apps making promises they can't back up. A famous investor asking sharp questions on stage doesn't automatically produce sharp answers. If you're a business leader scouting healthcare or wellness AI tools at Disrupt, the celebrity panel is a discovery mechanism, not a vetting one -- pair it with your own operations and security review before adopting anything you see pitched from that stage.
Conference season is a useful pulse-check on where AI vendor money and attention are flowing, but it's also the moment when sales pitches are sharpest and skepticism is hardest to hold onto. Our take: use Disrupt to build a shortlist, not a decision. The tools that matter to your business are the ones that hold up after the booth lights go off -- when you're comparing them against what you already run, whether that's a CRM, your helpdesk, or the workflows you've built in-house. A packed exhibit hall and a star-studded keynote are good theater. They're not proof of ROI.
Are you planning to attend Disrupt 2026 this year, and if so, are you going for the deal flow, the keynotes, or something else entirely?
Sources